Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,5,1.13 [1.07-1.19],8.19373823528118e-06,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FURIN,Furin,Wald ratio,1,1.31 [1.14-1.5],0.000166477418016566,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,MMP12,Macrophage metalloelastase,Inverse variance weighted,18,0.92 [0.88-0.96],0.000322700097784113,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,0.87 [0.81-0.94],0.000350711714553457,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,8,0.87 [0.8-0.94],0.000461028262412582,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,7,0.75 [0.63-0.89],0.0010333139525145,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ANG,Angiogenin,Inverse variance weighted,19,1.09 [1.03-1.15],0.00134762561064174,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,VWC2,Brorin,Inverse variance weighted,22,1.1 [1.03-1.16],0.00276765956280868,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.36 [1.1-1.68],0.0043006280659291,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,7,1.19 [1.05-1.34],0.00605685548967738,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,14,1.1 [1.03-1.18],0.0076433803004097,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,46,1.04 [1.01-1.07],0.00835148221297543,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PRCP,Lysosomal Pro-X carboxypeptidase,Inverse variance weighted,9,0.82 [0.71-0.95],0.00893752241819991,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FCRLB,Fc receptor-like B,Inverse variance weighted,61,1.06 [1.01-1.1],0.0110480190650017,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,11,1.13 [1.03-1.24],0.0113019381522736,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,2,0.87 [0.78-0.97],0.0114832443730769,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,0.94 [0.89-0.99],0.0120567369775811,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SHISA5,Protein shisa-5,Inverse variance weighted,5,1.35 [1.06-1.72],0.0157000739790695,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PDCD1,Programmed cell death protein 1,Inverse variance weighted,9,1.25 [1.04-1.51],0.0182922961990627,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TCN2,Transcobalamin-2,Inverse variance weighted,34,1.06 [1.01-1.11],0.0210437528123808,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PENK,Proenkephalin-A,Inverse variance weighted,19,1.09 [1.01-1.17],0.024376597461958,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SEMA3F,Semaphorin-3F,Inverse variance weighted,15,1.24 [1.03-1.49],0.0251064961178079,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,1.34 [1.04-1.74],0.0253855229912419,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SLAMF8,SLAM family member 8,Inverse variance weighted,25,1.03 [1-1.06],0.0258946796163642,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,0.93 [0.86-0.99],0.0263976643038354,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD300C,CMRF35-like molecule 6,Inverse variance weighted,12,0.95 [0.91-0.99],0.0272033715825732,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD300A,CMRF35-like molecule 8,Inverse variance weighted,5,1.1 [1.01-1.2],0.031657525720495,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.84 [0.71-0.99],0.0345206825720062,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,28,0.95 [0.91-1],0.0362957533345275,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,7,1.13 [1.01-1.26],0.0384911269594875,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,3,0.79 [0.63-0.99],0.0385566668901404,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,KRT18,"Keratin, type I cytoskeletal 18",Wald ratio,1,0.58 [0.34-0.98],0.0403726561481854,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SERPINF1,Pigment epithelium-derived factor,Inverse variance weighted,14,0.93 [0.87-1],0.0421964538417008,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,8,0.91 [0.83-1],0.0422230379525927,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,0.92 [0.85-1],0.0446115950730427,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SPON2,Spondin-2,Inverse variance weighted,4,1.11 [1-1.24],0.0457302028997927,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,30,1.05 [1-1.09],0.0522690207384226,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,1.08 [1-1.16],0.052397565189222,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,21,1.04 [1-1.08],0.0555346478493376,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,7,1.1 [1-1.21],0.05579387657614,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,0.87 [0.75-1],0.0558548866021041,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PALM2,Paralemmin-2,Inverse variance weighted,8,1.14 [1-1.31],0.0578470658765495,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CHGB,Secretogranin-1,Inverse variance weighted,27,1.04 [1-1.08],0.0581177774285884,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,9,0.91 [0.82-1],0.0600598485892015,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,0.94 [0.88-1.01],0.0735744088615032,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,1.34 [0.97-1.86],0.07538275870704,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,0.86 [0.73-1.02],0.0797814582578687,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CST3,Cystatin-C,Inverse variance weighted,10,1.07 [0.99-1.15],0.0844682516713328,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PI3,Elafin,Inverse variance weighted,10,1.07 [0.99-1.15],0.0878478711707304,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,4,1.11 [0.98-1.26],0.0879454862750654,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,17,0.94 [0.87-1.01],0.090107639038696,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,0.94 [0.86-1.01],0.0958724309663369,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,1.09 [0.99-1.2],0.0959655781971816,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,0.93 [0.86-1.01],0.0984678058099024,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,2,0.89 [0.77-1.02],0.0999159312131243,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,0.83 [0.66-1.04],0.101308132469693,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,5,1.13 [0.98-1.31],0.104398691537541,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,1.12 [0.98-1.29],0.105323272264299,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,32,0.96 [0.92-1.01],0.110970374917114,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CTSD,Cathepsin D,Inverse variance weighted,17,1.06 [0.99-1.13],0.115624699853398,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,1.04 [0.99-1.1],0.115680328951481,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,6,1.1 [0.98-1.25],0.118897767013788,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LGALS9,Galectin-9,Inverse variance weighted,26,1.04 [0.99-1.1],0.128414218371547,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LCN15,Lipocalin-15,Inverse variance weighted,20,0.96 [0.92-1.01],0.128853135897347,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,13,1.06 [0.98-1.13],0.129680026845294,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CCL21,C-C motif chemokine 21,Inverse variance weighted,4,0.87 [0.72-1.04],0.130951456302431,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,33,1.04 [0.99-1.11],0.135509537243854,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,49,1.02 [0.99-1.05],0.135939198164569,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,5,0.92 [0.82-1.03],0.136432731100913,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,8,1.09 [0.97-1.22],0.140037002737033,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,5,0.91 [0.81-1.03],0.141651630385158,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,8,1.06 [0.98-1.15],0.144067458566197,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GRN,Progranulin,Inverse variance weighted,7,0.94 [0.87-1.02],0.144088345521443,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GRPEL1,"GrpE protein homolog 1, mitochondrial",Wald ratio,1,0.71 [0.45-1.12],0.144468201024597,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,RNASET2,Ribonuclease T2,Inverse variance weighted,14,0.96 [0.91-1.01],0.149844043833457,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PLXNB2,Plexin-B2,Inverse variance weighted,27,1.02 [0.99-1.05],0.151637754841633,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CALCA,Calcitonin,Inverse variance weighted,5,0.87 [0.71-1.06],0.158175695231119,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NPY,Pro-neuropeptide Y,Inverse variance weighted,3,0.89 [0.76-1.05],0.158452647271579,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CFD,Complement factor D,Inverse variance weighted,11,1.06 [0.97-1.16],0.165004007007301,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,44,1.03 [0.99-1.07],0.166376974311721,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CLEC3B,Tetranectin,Inverse variance weighted,7,0.93 [0.84-1.03],0.168625474039355,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TMSB10,Thymosin beta-10,Wald ratio,1,0.75 [0.49-1.14],0.173242184787808,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CA12,Carbonic anhydrase 12,Inverse variance weighted,13,1.07 [0.97-1.17],0.176151904365796,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CA6,Carbonic anhydrase 6,Inverse variance weighted,31,1.03 [0.99-1.08],0.176756373347059,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,DPY30,Protein dpy-30 homolog,Wald ratio,1,0.68 [0.39-1.19],0.178875330270608,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FGF5,Fibroblast growth factor 5,Inverse variance weighted,36,1.03 [0.99-1.07],0.178896493484917,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,4,0.85 [0.68-1.08],0.180150913569955,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,6,0.92 [0.82-1.04],0.183332258149791,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TFF1,Trefoil factor 1,Inverse variance weighted,8,1.06 [0.97-1.16],0.185132689270088,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LMOD1,Leiomodin-1,Inverse variance weighted,5,1.15 [0.93-1.41],0.188343891892599,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,HGF,Hepatocyte growth factor,Inverse variance weighted,2,1.2 [0.91-1.57],0.190719683603718,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.08 [0.96-1.22],0.192682722915612,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,4,0.94 [0.85-1.03],0.193384872956078,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SIGLEC1,Sialoadhesin,Inverse variance weighted,20,0.96 [0.91-1.02],0.195352141913,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,MDK,Midkine,Inverse variance weighted,4,1.11 [0.95-1.31],0.19595368839877,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,46,1.02 [0.99-1.06],0.19899962962394,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,EFNA1,Ephrin-A1,Inverse variance weighted,11,1.05 [0.98-1.13],0.199865319344207,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,0.95 [0.88-1.03],0.203038895116034,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,RSPO3,R-spondin-3,Inverse variance weighted,6,1.08 [0.96-1.23],0.207844641472054,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,RNASE6,Ribonuclease K6,Inverse variance weighted,15,1.03 [0.98-1.08],0.210779623356076,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,1.08 [0.96-1.21],0.213356590760906,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,8,1.11 [0.94-1.31],0.218645149168672,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,0.97 [0.93-1.02],0.219183955717463,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,BSG,Basigin,Wald ratio,1,0.9 [0.75-1.07],0.232592459363084,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GM2A,Ganglioside GM2 activator,Inverse variance weighted,24,1.03 [0.98-1.07],0.23376914755355,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,1.28 [0.85-1.94],0.234347664633389,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,22,0.96 [0.9-1.03],0.234586576071809,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,EDN1,Endothelin-1,Inverse variance weighted,3,1.08 [0.95-1.22],0.235413157155024,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,1.05 [0.97-1.14],0.235910127677114,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,0.98 [0.94-1.01],0.236503004591292,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PVR,Poliovirus receptor,Inverse variance weighted,27,1.02 [0.99-1.05],0.240589455605018,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,1.17 [0.9-1.53],0.241621984804107,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TFF3,Trefoil factor 3,Inverse variance weighted,5,0.9 [0.76-1.07],0.242592440520259,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GPRC5C,G-protein coupled receptor family C group 5 member C,Wald ratio,1,1.13 [0.92-1.4],0.244546847568763,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,19,1.05 [0.97-1.14],0.245010474887827,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FABP5,Fatty acid-binding protein 5,Wald ratio,1,1.11 [0.93-1.32],0.245532850404107,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,13,0.97 [0.92-1.02],0.24580648698999,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,1.02 [0.99-1.05],0.249081693402185,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,1.39 [0.79-2.44],0.253284366592805,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,1.04 [0.97-1.11],0.256472584203206,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,0.66 [0.32-1.35],0.258731426506867,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,1.05 [0.97-1.14],0.262841375842724,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,8,1.06 [0.96-1.16],0.264306715331919,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,12,1.03 [0.98-1.08],0.267675511017865,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,3,0.96 [0.91-1.03],0.272916754126116,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,10,0.96 [0.89-1.03],0.274059090896419,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,4,0.88 [0.71-1.1],0.274148371435447,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,10,0.95 [0.87-1.04],0.275402789874035,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,9,0.96 [0.89-1.04],0.278247248153837,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,0.97 [0.92-1.03],0.279712623007761,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,AOC3,Membrane primary amine oxidase,Inverse variance weighted,18,0.98 [0.93-1.02],0.285688797396622,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,7,1.04 [0.96-1.13],0.290155866337769,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,11,0.92 [0.79-1.07],0.290866023900821,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CCN4,CCN family member 4,Inverse variance weighted,27,0.97 [0.92-1.03],0.29750833225936,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,10,1.04 [0.96-1.13],0.299946774123977,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,0.89 [0.72-1.11],0.308425613791435,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,16,1.04 [0.97-1.11],0.310984044432395,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,11,1.04 [0.97-1.12],0.311722645272566,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,29,0.98 [0.95-1.02],0.31183128368427,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,4,1.09 [0.92-1.29],0.319946790780736,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CCL22,C-C motif chemokine 22,Inverse variance weighted,6,0.94 [0.83-1.06],0.323558736914685,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,RTBDN,Retbindin,Inverse variance weighted,3,0.93 [0.82-1.07],0.32400900801032,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CCL20,C-C motif chemokine 20,Inverse variance weighted,2,1.15 [0.87-1.53],0.326190385515856,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,8,1.05 [0.95-1.17],0.326365906924497,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ADM,Pro-adrenomedullin,Inverse variance weighted,2,0.78 [0.48-1.27],0.327264855285041,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GUCA2A,Guanylin,Inverse variance weighted,9,0.95 [0.85-1.06],0.333121692819485,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,1.09 [0.92-1.28],0.336152568327158,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,RNASE4,Ribonuclease 4,Inverse variance weighted,11,1.04 [0.96-1.13],0.337505943360248,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,4,0.95 [0.87-1.05],0.339518978462902,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL19,Interleukin-19,Inverse variance weighted,11,1.04 [0.96-1.11],0.345843616574833,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,7,1.13 [0.88-1.46],0.348365653347611,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CNTN5,Contactin-5,Inverse variance weighted,28,0.98 [0.93-1.03],0.352272529909276,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,24,1.02 [0.98-1.06],0.353439631137863,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,1.04 [0.95-1.14],0.355353361251425,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PGF,Placenta growth factor,Inverse variance weighted,2,0.75 [0.4-1.4],0.361983566367532,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,17,0.98 [0.92-1.03],0.375211353950671,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NPPB,Natriuretic peptides B,Inverse variance weighted,3,0.94 [0.83-1.08],0.376620427637645,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CDH2,Cadherin-2,Inverse variance weighted,3,1.12 [0.87-1.43],0.38984304878508,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,KLK11,Kallikrein-11,Inverse variance weighted,6,1.02 [0.97-1.08],0.394258784957864,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,AMBP,Protein AMBP,Inverse variance weighted,3,0.92 [0.75-1.12],0.395571670061586,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,0.92 [0.77-1.11],0.400069790199676,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ENAH,Protein enabled homolog,Inverse variance weighted,2,1.17 [0.81-1.71],0.400911900369316,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CALB2,Calretinin,Wald ratio,1,1.18 [0.8-1.76],0.403799575929872,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,4,1.05 [0.94-1.16],0.404384895472124,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,EGFR,Epidermal growth factor receptor,Inverse variance weighted,7,1.08 [0.9-1.29],0.410603900493769,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,MZB1,Marginal zone B- and B1-cell-specific protein,Wald ratio,1,1.32 [0.68-2.57],0.412458941762009,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SCG2,Secretogranin-2,Wald ratio,1,1.24 [0.74-2.07],0.414490343982261,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,MMP3,Stromelysin-1,Inverse variance weighted,34,1.03 [0.96-1.1],0.415432819892784,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,1.1 [0.87-1.38],0.419936088361478,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LAYN,Layilin,Inverse variance weighted,20,1.03 [0.96-1.1],0.422383277509167,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,HIP1R,Huntingtin-interacting protein 1-related protein,Wald ratio,1,1.12 [0.85-1.46],0.424414153428003,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CHGA,Chromogranin-A,Inverse variance weighted,3,1.09 [0.88-1.34],0.425061883836273,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LGALS4,Galectin-4,Inverse variance weighted,4,0.94 [0.81-1.09],0.425290111833638,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ADGRD1,Adhesion G-protein coupled receptor D1,Inverse variance weighted,22,1.02 [0.98-1.06],0.426970273456512,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD302,CD302 antigen,Inverse variance weighted,9,0.96 [0.88-1.06],0.427740457999343,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,0.94 [0.8-1.1],0.429079131589373,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,16,0.98 [0.93-1.03],0.430949264312076,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,0.94 [0.79-1.11],0.434707340122306,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,0.92 [0.74-1.14],0.437080259501851,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,1.04 [0.94-1.16],0.437835181656657,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,UMOD,Uromodulin,Inverse variance weighted,29,1.01 [0.98-1.05],0.437856479083665,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,0.97 [0.89-1.05],0.442096121823724,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,REN,Renin,Inverse variance weighted,4,1.03 [0.95-1.13],0.442784322456814,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,8,0.96 [0.87-1.06],0.443243508672164,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,Wald ratio,1,0.89 [0.66-1.2],0.443400819554674,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,22,0.98 [0.92-1.04],0.446399756774835,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,0.91 [0.71-1.16],0.447552213409318,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CTSO,Cathepsin O,Inverse variance weighted,6,0.94 [0.81-1.1],0.449410341557507,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,8,1.04 [0.94-1.14],0.449734448130895,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,26,0.97 [0.89-1.05],0.452447101163364,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CTSZ,Cathepsin Z,Inverse variance weighted,3,1.04 [0.94-1.16],0.455374701856453,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,6,0.94 [0.8-1.11],0.459779179931455,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,0.85 [0.55-1.31],0.46111970019146,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NUCB2,Nucleobindin-2,Inverse variance weighted,24,0.98 [0.91-1.04],0.474323444744163,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,0.95 [0.84-1.09],0.477578359538459,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,1.02 [0.96-1.09],0.478097059929543,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,C7,Complement component C7,Inverse variance weighted,38,1.01 [0.98-1.05],0.480103920521689,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,44,0.98 [0.94-1.03],0.480166073297348,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,14,1.03 [0.94-1.14],0.489622022482017,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,1.02 [0.96-1.09],0.490965892756211,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LGALS1,Galectin-1,Inverse variance weighted,6,1.04 [0.94-1.15],0.491317849371633,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,HNMT,Histamine N-methyltransferase,Inverse variance weighted,27,1.01 [0.98-1.05],0.491640543310494,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD276,CD276 antigen,Inverse variance weighted,20,1.02 [0.97-1.07],0.491784617793915,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,33,1.02 [0.97-1.07],0.492427563533034,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CXCL11,C-X-C motif chemokine 11,Inverse variance weighted,7,1.03 [0.94-1.14],0.494652405915603,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,OGN,Mimecan,Inverse variance weighted,30,0.98 [0.93-1.04],0.494817071403025,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TFF2,Trefoil factor 2,Inverse variance weighted,5,0.95 [0.82-1.1],0.495200621746011,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,14,0.98 [0.92-1.04],0.495739014688045,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,11,0.97 [0.9-1.05],0.497764719358888,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,RBP2,Retinol-binding protein 2,Wald ratio,1,1.15 [0.77-1.71],0.502373136285096,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,0.94 [0.79-1.12],0.503177303498521,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL15,Interleukin-15,Wald ratio,1,2.15 [0.23-20.36],0.504203187372972,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,1.08 [0.85-1.37],0.513036366711402,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,HYAL1,Hyaluronidase-1,Inverse variance weighted,5,0.97 [0.89-1.06],0.515742543008133,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,0.95 [0.81-1.11],0.516500791936657,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,12,1.04 [0.92-1.18],0.519282797437614,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,13,0.97 [0.88-1.06],0.525554332313741,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PRSS8,Prostasin,Inverse variance weighted,5,0.94 [0.77-1.14],0.52697444911761,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,6,1.02 [0.95-1.1],0.529174648553441,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ADA2,Adenosine deaminase 2,Inverse variance weighted,8,1.03 [0.95-1.11],0.529961581562192,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,10,1.03 [0.94-1.12],0.53095724898813,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ELN,Elastin,Inverse variance weighted,2,1.11 [0.79-1.57],0.531472313586266,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,20,0.99 [0.95-1.03],0.53552916092161,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,6,0.96 [0.86-1.08],0.540660676812845,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,15,0.98 [0.91-1.05],0.543636890797507,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SFTPA2,Pulmonary surfactant-associated protein A2,Inverse variance weighted,19,1.01 [0.97-1.05],0.544897800626283,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,AREG,Amphiregulin,Inverse variance weighted,3,0.95 [0.81-1.12],0.546474185834335,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CTSL,Cathepsin L1,Wald ratio,1,1.18 [0.69-1.99],0.549002347782833,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LMNB2,Lamin-B2,Wald ratio,1,0.83 [0.46-1.52],0.550006897653446,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,10,1.03 [0.94-1.13],0.550553967656069,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,5,1.03 [0.92-1.16],0.554469344533983,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,1.1 [0.8-1.52],0.556156152005064,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,3,0.93 [0.74-1.18],0.55823799674599,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,3,0.95 [0.82-1.12],0.559828206989791,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,XCL1,Lymphotactin,Inverse variance weighted,31,1.01 [0.97-1.06],0.561415421179544,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,THBS2,Thrombospondin-2,Inverse variance weighted,16,1.02 [0.96-1.08],0.562697150217363,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FOLR1,Folate receptor alpha,Inverse variance weighted,5,0.93 [0.72-1.2],0.563507977334398,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,2,0.9 [0.62-1.3],0.567352111193055,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,3,1.12 [0.77-1.63],0.567353251313316,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NECTIN2,Nectin-2,Inverse variance weighted,5,0.98 [0.91-1.05],0.568353845867804,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,1.01 [0.97-1.05],0.570749467032954,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,RTN4R,Reticulon-4 receptor,Inverse variance weighted,15,1.02 [0.96-1.07],0.571075700182292,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,3,0.96 [0.83-1.11],0.577106343521032,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,34,1.01 [0.97-1.06],0.593905691360336,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PGA4,Pepsin A-4,Inverse variance weighted,2,1.09 [0.79-1.51],0.594087159128007,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,12,1.02 [0.95-1.09],0.596289227798131,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,DSC2,Desmocollin-2,Inverse variance weighted,9,0.98 [0.89-1.07],0.601376589052506,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,0.99 [0.94-1.04],0.602722665433173,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,0.89 [0.57-1.39],0.602822891090803,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,5,1.07 [0.84-1.36],0.605211696082164,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,MFGE8,Lactadherin,Inverse variance weighted,11,1.02 [0.95-1.1],0.606681670627885,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,1.03 [0.93-1.14],0.607578480131584,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD83,CD83 antigen,Inverse variance weighted,5,1.05 [0.88-1.24],0.61101142222051,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD7,T-cell antigen CD7,Inverse variance weighted,8,0.99 [0.94-1.04],0.612208201738444,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ITGA5,Integrin alpha-5,Wald ratio,1,0.9 [0.6-1.36],0.616107839020365,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,0.98 [0.93-1.05],0.617776244900133,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LY96,Lymphocyte antigen 96,Inverse variance weighted,3,1.09 [0.77-1.54],0.620348018529515,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,0.97 [0.86-1.09],0.621387924102231,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.91 [0.61-1.35],0.626423240497315,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,0.98 [0.88-1.08],0.630225866422767,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,WFDC1,WAP four-disulfide core domain protein 1,Inverse variance weighted,6,1.02 [0.95-1.09],0.633289497955489,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,10,0.98 [0.89-1.07],0.634345003901184,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,0.96 [0.82-1.13],0.63902844743917,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,0.96 [0.82-1.13],0.63933822484356,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,3,0.97 [0.85-1.11],0.642988083599961,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,16,1.01 [0.96-1.06],0.643910088561184,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,STC1,Stanniocalcin-1,Inverse variance weighted,2,1.09 [0.76-1.56],0.649061502930746,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PCDH1,Protocadherin-1,Wald ratio,1,0.93 [0.69-1.26],0.649577369785701,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CGA,Glycoprotein hormones alpha chain,Wald ratio,1,0.85 [0.42-1.72],0.649750994274159,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,EFNA4,Ephrin-A4,Inverse variance weighted,3,1.06 [0.82-1.38],0.650441098140832,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CLMP,CXADR-like membrane protein,Inverse variance weighted,12,0.98 [0.92-1.06],0.653933895007818,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,10,1.02 [0.94-1.1],0.654293721596098,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,1.03 [0.91-1.16],0.655421469485451,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,BCAN,Brevican core protein,Inverse variance weighted,3,0.98 [0.88-1.08],0.656638412158939,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SPON1,Spondin-1,Inverse variance weighted,21,1.01 [0.95-1.08],0.660195624569566,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL18,Interleukin-18,Inverse variance weighted,16,0.97 [0.85-1.11],0.664515217599626,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,1.07 [0.8-1.43],0.665067054860284,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,4,0.94 [0.7-1.26],0.665440284639739,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SFTPA1,Pulmonary surfactant-associated protein A1,Inverse variance weighted,6,1.02 [0.94-1.1],0.668891446102951,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,0.98 [0.88-1.08],0.66899046489025,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Wald ratio,1,0.94 [0.7-1.26],0.66940359498495,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,MUC13,Mucin-13,Inverse variance weighted,9,1.03 [0.91-1.16],0.677476581790252,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,1.01 [0.95-1.08],0.684240679783861,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,1.02 [0.94-1.1],0.686128906885324,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,0.92 [0.63-1.36],0.688343518328285,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,14,1.01 [0.96-1.06],0.690631348601792,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NFASC,Neurofascin,Inverse variance weighted,15,1.01 [0.95-1.08],0.699732333577901,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,STC2,Stanniocalcin-2,Inverse variance weighted,3,1.05 [0.81-1.37],0.700277039016101,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CPM,Carboxypeptidase M,Inverse variance weighted,4,1.05 [0.82-1.34],0.704248630800768,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,5,1.03 [0.89-1.19],0.705528244632317,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,0.98 [0.85-1.11],0.710810727118671,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SPP1,Osteopontin,Inverse variance weighted,8,0.97 [0.82-1.14],0.713356086836192,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CCN3,CCN family member 3,Inverse variance weighted,19,1.01 [0.94-1.09],0.713686711996447,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Wald ratio,1,0.95 [0.7-1.27],0.719332326120146,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,22,1.01 [0.94-1.09],0.720391587224513,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,23,1.01 [0.95-1.07],0.726469865128244,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD59,CD59 glycoprotein,Inverse variance weighted,4,1.02 [0.9-1.15],0.730277394275686,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,5,1.02 [0.89-1.18],0.737795704942521,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,12,0.99 [0.92-1.06],0.738078414307545,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,27,1.01 [0.97-1.05],0.740173725997029,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,0.9 [0.48-1.7],0.746469498538482,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SEPTIN8,Septin-8,Inverse variance weighted,2,0.94 [0.63-1.4],0.749963340963582,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,COLEC12,Collectin-12,Inverse variance weighted,11,1.01 [0.93-1.11],0.752906201600516,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CSTB,Cystatin-B,Inverse variance weighted,28,1.01 [0.96-1.06],0.758557494703366,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,WNT9A,Protein Wnt-9a,Inverse variance weighted,3,1.05 [0.76-1.45],0.759387773703547,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,3,0.96 [0.71-1.28],0.759672220625812,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD160,CD160 antigen,Inverse variance weighted,11,1.01 [0.93-1.1],0.770035028222602,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,MME,Neprilysin,Inverse variance weighted,3,0.96 [0.71-1.29],0.770920474903474,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,6,0.98 [0.85-1.13],0.771657594093164,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,0.99 [0.93-1.06],0.774438741680521,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LAMB1,Laminin subunit beta-1,Inverse variance weighted,35,0.99 [0.96-1.03],0.777471129308579,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,4,1.02 [0.9-1.15],0.786900669552626,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,KLK4,Kallikrein-4,Inverse variance weighted,17,1.01 [0.96-1.06],0.790326754861974,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NPPC,C-type natriuretic peptide,Wald ratio,1,0.92 [0.52-1.66],0.791274263547227,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,1 [0.97-1.04],0.79154183980377,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,28,0.99 [0.95-1.04],0.795305791792905,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CCL14,C-C motif chemokine 14,Inverse variance weighted,12,0.99 [0.94-1.05],0.800028790234787,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,2,0.96 [0.7-1.31],0.804282799333609,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,4,1.01 [0.91-1.13],0.806374101694086,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,6,1 [0.97-1.04],0.813847618205168,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CCL3,C-C motif chemokine 3,Inverse variance weighted,9,0.99 [0.91-1.07],0.814625672944681,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,21,1.01 [0.93-1.09],0.817965831441626,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.97 [0.77-1.23],0.818290599379419,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CCL23,C-C motif chemokine 23,Inverse variance weighted,17,0.99 [0.95-1.04],0.819147517131902,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,1.01 [0.9-1.13],0.821651407028865,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PRSS2,Trypsin-2,Inverse variance weighted,3,1.02 [0.87-1.19],0.829709547145358,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FAM3C,Protein FAM3C,Inverse variance weighted,2,1.05 [0.69-1.59],0.830277523385129,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CCL16,C-C motif chemokine 16,Inverse variance weighted,19,1 [0.96-1.03],0.833131824768532,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NECTIN4,Nectin-4,Inverse variance weighted,7,1.01 [0.93-1.09],0.834093332686475,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FSTL1,Follistatin-related protein 1,Inverse variance weighted,3,0.97 [0.72-1.3],0.834675277224909,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,1 [0.97-1.04],0.836570060647133,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,2,0.97 [0.76-1.25],0.83748840559805,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,0.99 [0.89-1.1],0.840522609545559,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,RSPO1,R-spondin-1,Inverse variance weighted,5,0.99 [0.9-1.09],0.845749988417405,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SDC1,Syndecan-1,Inverse variance weighted,2,1.02 [0.85-1.21],0.846581622206048,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,13,1.01 [0.94-1.07],0.848656075292708,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,26,0.99 [0.92-1.07],0.852101920956013,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,1.01 [0.9-1.13],0.85313582255045,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,HSPB6,Heat shock protein beta-6,Wald ratio,1,1.06 [0.57-1.95],0.855140623593503,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.04 [0.69-1.56],0.856377378638503,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,1.01 [0.92-1.1],0.860012270382077,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL17C,Interleukin-17C,Inverse variance weighted,3,1.02 [0.85-1.22],0.861014220744342,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,16,1.01 [0.89-1.14],0.861790158785532,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CCL7,C-C motif chemokine 7,Inverse variance weighted,3,0.97 [0.68-1.39],0.863419386576214,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NOMO1,Nodal modulator 1,Inverse variance weighted,2,0.99 [0.83-1.17],0.868026874174295,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,MSLN,Mesothelin,Inverse variance weighted,25,1 [0.96-1.05],0.868447892458987,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,18,1 [0.96-1.05],0.872661149113668,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,DTNB,Dystrobrevin beta,Inverse variance weighted,2,0.96 [0.56-1.63],0.87447763526338,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD55,Complement decay-accelerating factor,Inverse variance weighted,15,1 [0.94-1.05],0.87549781853055,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,1.01 [0.88-1.16],0.875678720088167,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CDH1,Cadherin-1,Wald ratio,1,0.96 [0.57-1.62],0.87594946768565,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,4,0.98 [0.71-1.35],0.887047378266023,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FBLN2,Fibulin-2,Inverse variance weighted,11,1.01 [0.93-1.09],0.889334791159036,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CLGN,Calmegin,Inverse variance weighted,23,1 [0.94-1.05],0.889593618853416,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,0.99 [0.8-1.21],0.890952618931157,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,1.01 [0.9-1.13],0.892227723651792,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,MMP7,Matrilysin,Inverse variance weighted,13,1.01 [0.91-1.12],0.893413269818306,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,8,1 [0.94-1.07],0.893606604106472,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD27,CD27 antigen,Inverse variance weighted,9,0.99 [0.91-1.08],0.895168325476455,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,0.98 [0.76-1.28],0.905669670723226,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PSAP,Prosaposin,Inverse variance weighted,5,1.01 [0.9-1.12],0.907157132421566,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,1.01 [0.85-1.2],0.907553696061869,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,1.01 [0.82-1.24],0.912384964089426,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,1.01 [0.85-1.19],0.91466293618317,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,8,1 [0.93-1.09],0.918224714743788,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,22,1 [0.94-1.06],0.919020784463506,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,1.01 [0.88-1.15],0.921741035491239,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,HSPA2,Heat shock-related 70 kDa protein 2,Inverse variance weighted,3,0.99 [0.79-1.24],0.924739143370421,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,0.99 [0.88-1.12],0.925552357416038,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,0.98 [0.7-1.38],0.926071966811697,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,10,1 [0.93-1.07],0.927025611570973,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,OMG,Oligodendrocyte-myelin glycoprotein,Wald ratio,1,1.01 [0.74-1.39],0.92942482172986,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,1 [0.95-1.06],0.929554241674411,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,1.01 [0.85-1.19],0.935811282131139,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,DLL1,Delta-like protein 1,Inverse variance weighted,7,1 [0.89-1.12],0.935872344615917,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD46,Membrane cofactor protein,Wald ratio,1,0.99 [0.75-1.3],0.938007475820505,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1 [0.91-1.09],0.942807369011784,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,0.99 [0.84-1.18],0.943030283479461,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FAM3B,Protein FAM3B,Inverse variance weighted,18,1 [0.96-1.04],0.943946496301225,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,INHBB,Inhibin beta B chain,Inverse variance weighted,10,1 [0.93-1.08],0.945707558388536,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SNCG,Gamma-synuclein,Inverse variance weighted,36,1 [0.96-1.04],0.946493209901285,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,14,1 [0.93-1.08],0.949626288121134,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,2,1.01 [0.65-1.57],0.949826898256466,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,30,1 [0.96-1.04],0.94998897557787,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,3,1.01 [0.85-1.2],0.953096631440665,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,1.01 [0.81-1.25],0.954539975026798,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,1 [0.95-1.05],0.956347038565239,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,7,1 [0.93-1.08],0.960457495884215,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,28,1 [0.94-1.06],0.965224620560177,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CBLIF,Cobalamin binding intrinsic factor,Inverse variance weighted,2,1 [0.77-1.3],0.971288439197032,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,1 [0.85-1.18],0.973496725722942,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,1 [0.9-1.11],0.974694623151144,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,OCLN,Occludin,Inverse variance weighted,2,1.01 [0.69-1.46],0.975162315242207,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CDH3,Cadherin-3,Inverse variance weighted,2,1 [0.75-1.32],0.9766798089073,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,1 [0.75-1.34],0.977731511985549,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,24,1 [0.94-1.06],0.978214952494555,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,JAM2,Junctional adhesion molecule B,Inverse variance weighted,2,1 [0.69-1.47],0.980537626747273,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,AGRN,Agrin,Inverse variance weighted,17,1 [0.93-1.08],0.987605595574938,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,1 [0.69-1.45],0.995915780366084,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,1 [0.56-1.77],0.995975481793009,cis
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,8.54 [5.14-14.19],1.22322986190908e-16,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL6,Interleukin-6,Inverse variance weighted,6,0.79 [0.71-0.88],9.14065425543528e-06,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL15RA,Interleukin-15 receptor subunit alpha,Wald ratio,1,0.32 [0.18-0.58],0.000145054631956807,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,1.1 [1.05-1.16],0.000170277197710533,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,2.01 [1.39-2.92],0.00022359154583683,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,0.61 [0.44-0.83],0.00204238270346751,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CA6,Carbonic anhydrase 6,Inverse variance weighted,20,0.79 [0.67-0.92],0.00315411886774999,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,6,1.65 [1.18-2.3],0.00325961879044248,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SHISA5,Protein shisa-5,Inverse variance weighted,12,1.35 [1.1-1.66],0.00373982500751612,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,1.27 [1.08-1.49],0.00407117549510067,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.65 [0.48-0.89],0.00632665914399634,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD302,CD302 antigen,Inverse variance weighted,11,0.85 [0.76-0.96],0.00743700882430401,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,6,0.72 [0.57-0.92],0.00824748883823023,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CTSL,Cathepsin L1,Inverse variance weighted,29,1.11 [1.03-1.2],0.0093889045927541,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,4,1.37 [1.08-1.75],0.0098630149847208,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,1.43 [1.09-1.87],0.0106627763118642,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,0.95 [0.91-0.99],0.0108880153996064,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL17C,Interleukin-17C,Inverse variance weighted,5,1.34 [1.06-1.71],0.0151387741829722,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,0.61 [0.41-0.91],0.0157279577414246,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,MUC13,Mucin-13,Inverse variance weighted,3,0.62 [0.43-0.92],0.0162064268995908,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,24,1.16 [1.03-1.3],0.0162299287574626,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PI3,Elafin,Inverse variance weighted,18,1.08 [1.01-1.16],0.0181764326344968,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,4,1.31 [1.05-1.65],0.0187770017340557,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,0.83 [0.72-0.97],0.0202544499796662,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,1.19 [1.03-1.38],0.0213704608918531,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,3,1.28 [1.03-1.58],0.0244405626141831,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD83,CD83 antigen,Inverse variance weighted,14,0.84 [0.73-0.98],0.024933524561748,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,1.21 [1.02-1.42],0.0260564284129343,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,1.28 [1.03-1.58],0.0270029187872968,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,19,1.19 [1.02-1.38],0.027068771274925,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LGALS4,Galectin-4,Inverse variance weighted,15,0.93 [0.88-0.99],0.0306144185258344,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,4,1.3 [1.02-1.67],0.0347362282837153,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PRCP,Lysosomal Pro-X carboxypeptidase,Inverse variance weighted,22,1.14 [1.01-1.29],0.0355939796644302,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SRPX,Sushi repeat-containing protein SRPX,Inverse variance weighted,2,1.55 [1.02-2.34],0.0384741668985202,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,1.8 [1.03-3.15],0.0402141689934093,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GRN,Progranulin,Inverse variance weighted,46,1.05 [1-1.09],0.0458331694452236,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,1.44 [1.01-2.07],0.0463040204561713,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,1.37 [1-1.87],0.0466241302120733,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PALM2,Paralemmin-2,Inverse variance weighted,9,1.14 [1-1.29],0.0488508004232456,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LCN15,Lipocalin-15,Inverse variance weighted,22,0.96 [0.92-1],0.0499367786751742,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,STC2,Stanniocalcin-2,Inverse variance weighted,10,1.25 [1-1.56],0.0532432334732263,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PGA4,Pepsin A-4,Inverse variance weighted,7,0.83 [0.69-1],0.0556543898431322,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,4,1.41 [0.99-2.01],0.0592343494092971,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,8,0.81 [0.65-1.01],0.0595656650802897,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NFASC,Neurofascin,Inverse variance weighted,6,0.78 [0.6-1.01],0.0602720814677469,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ANG,Angiogenin,Inverse variance weighted,8,1.26 [0.99-1.61],0.0639373200775098,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,2,0.65 [0.41-1.03],0.0654221020027632,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,9,1.22 [0.99-1.51],0.0657910406146582,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,0.96 [0.91-1],0.0701222343707217,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,AGRN,Agrin,Inverse variance weighted,14,1.18 [0.99-1.41],0.0721624366820097,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,0.62 [0.36-1.05],0.0756294840002042,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,7,1.19 [0.98-1.44],0.0760171609952955,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,RTN4R,Reticulon-4 receptor,Inverse variance weighted,8,1.18 [0.98-1.42],0.0760786167911041,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CDH3,Cadherin-3,Inverse variance weighted,10,1.37 [0.97-1.95],0.0764345273105081,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CLGN,Calmegin,Inverse variance weighted,6,0.86 [0.73-1.02],0.0772112073841037,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FSTL1,Follistatin-related protein 1,Inverse variance weighted,12,1.19 [0.98-1.43],0.0794447183388233,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,MFGE8,Lactadherin,Inverse variance weighted,15,1.17 [0.98-1.39],0.0801069744585941,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LGALS9,Galectin-9,Inverse variance weighted,36,1.05 [0.99-1.11],0.0809078796639657,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CPM,Carboxypeptidase M,Inverse variance weighted,19,1.12 [0.98-1.28],0.0835697060011541,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,12,0.92 [0.83-1.01],0.0836713389376549,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,0.79 [0.6-1.03],0.0837702376862124,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,VWC2,Brorin,Inverse variance weighted,12,1.15 [0.98-1.34],0.0886229360777685,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,21,0.94 [0.87-1.01],0.0925207853056672,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,BSG,Basigin,Inverse variance weighted,6,1.28 [0.96-1.7],0.0946774739250716,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,0.77 [0.56-1.05],0.0964938230831309,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,0.78 [0.58-1.05],0.0978412054367919,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,RNASE6,Ribonuclease K6,Inverse variance weighted,4,0.77 [0.56-1.05],0.102279750052536,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PENK,Proenkephalin-A,Inverse variance weighted,15,1.1 [0.98-1.23],0.102588054262402,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,8,1.07 [0.99-1.15],0.104867073299225,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,1.38 [0.93-2.05],0.106954827276898,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NPY,Pro-neuropeptide Y,Inverse variance weighted,15,1.17 [0.96-1.43],0.109680474559825,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,12,1.12 [0.97-1.29],0.110602049249743,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,1.32 [0.93-1.86],0.116306665253487,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,13,0.93 [0.84-1.02],0.123206765176966,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CFD,Complement factor D,Wald ratio,1,0.67 [0.4-1.12],0.126880425740557,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FBLN2,Fibulin-2,Inverse variance weighted,6,0.78 [0.57-1.07],0.130107362083611,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CRLF1,Cytokine receptor-like factor 1,Inverse variance weighted,15,1.2 [0.94-1.53],0.141446456283358,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,7,0.81 [0.62-1.07],0.142397469367656,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GPRC5C,G-protein coupled receptor family C group 5 member C,Inverse variance weighted,7,1.13 [0.96-1.32],0.142838546662665,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,AOC3,Membrane primary amine oxidase,Inverse variance weighted,33,0.97 [0.93-1.01],0.147062716514271,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FCRLB,Fc receptor-like B,Inverse variance weighted,10,0.9 [0.78-1.04],0.148380123651939,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,10,0.9 [0.77-1.04],0.151378552684991,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,DLL1,Delta-like protein 1,Inverse variance weighted,6,1.18 [0.94-1.47],0.15497895111853,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TGFA,Protransforming growth factor alpha,Inverse variance weighted,9,1.12 [0.96-1.31],0.155991433407526,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,1.19 [0.93-1.52],0.157773522479493,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,1.19 [0.93-1.53],0.15782162647193,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,10,1.15 [0.95-1.39],0.159925941857843,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ADGRD1,Adhesion G-protein coupled receptor D1,Inverse variance weighted,15,0.88 [0.74-1.05],0.1600833538005,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,0.92 [0.81-1.04],0.164327884257152,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,6,0.86 [0.69-1.07],0.16728210934244,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,7,0.76 [0.52-1.12],0.1694753708907,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,0.84 [0.66-1.08],0.172147243056409,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,14,0.9 [0.77-1.05],0.175820565336401,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ELN,Elastin,Inverse variance weighted,10,0.82 [0.6-1.11],0.188429067753497,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,1.15 [0.93-1.4],0.190057659871325,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SDC1,Syndecan-1,Inverse variance weighted,12,1.1 [0.95-1.28],0.190719234389648,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.08 [0.96-1.22],0.192682722915612,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,1.17 [0.92-1.48],0.196078117948781,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,25,0.94 [0.85-1.04],0.198111177757797,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,KRT18,"Keratin, type I cytoskeletal 18",Inverse variance weighted,7,1.1 [0.95-1.27],0.201965384974737,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD276,CD276 antigen,Inverse variance weighted,24,0.95 [0.88-1.03],0.202306146331954,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,11,0.91 [0.78-1.05],0.203898647074721,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ITGA5,Integrin alpha-5,Inverse variance weighted,18,0.93 [0.84-1.04],0.206948848665623,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,9,1.17 [0.92-1.48],0.207187698071542,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,1.14 [0.93-1.39],0.210291853660404,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LMOD1,Leiomodin-1,Inverse variance weighted,6,1.11 [0.94-1.3],0.210343405572036,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CA12,Carbonic anhydrase 12,Inverse variance weighted,9,0.89 [0.75-1.07],0.211449155354645,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NOMO1,Nodal modulator 1,Inverse variance weighted,24,1.03 [0.98-1.08],0.214062417625243,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL19,Interleukin-19,Inverse variance weighted,10,0.95 [0.87-1.03],0.215211932044023,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,4,1.15 [0.92-1.42],0.216205479723387,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,5,1.26 [0.87-1.82],0.217053502922622,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CBLIF,Cobalamin binding intrinsic factor,Inverse variance weighted,57,0.97 [0.93-1.02],0.2179166797347,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,THY1,Thy-1 membrane glycoprotein,Wald ratio,1,1.47 [0.8-2.71],0.21923449330514,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,0.85 [0.66-1.1],0.220253362726164,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,10,0.87 [0.69-1.09],0.222535033575531,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,6,0.84 [0.64-1.11],0.224748112012599,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,7,0.89 [0.74-1.07],0.226478504342153,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,7,1.2 [0.89-1.61],0.22669197951241,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,1.24 [0.88-1.75],0.227006409862347,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,1.22 [0.88-1.68],0.230020289503184,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,2,1.25 [0.87-1.81],0.230215126741486,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,6,1.12 [0.93-1.36],0.232952122206069,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,1.15 [0.91-1.44],0.234180701121693,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,0.91 [0.78-1.06],0.234389772613557,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LY96,Lymphocyte antigen 96,Inverse variance weighted,16,1.09 [0.95-1.25],0.236991715113063,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,6,1.15 [0.91-1.45],0.241026553101181,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,B2M,Beta-2-microglobulin,Inverse variance weighted,7,1.26 [0.85-1.86],0.241876510370814,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,6,0.83 [0.61-1.13],0.242021682040778,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PRSS8,Prostasin,Inverse variance weighted,14,1.07 [0.95-1.21],0.244110380261292,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PDCD1,Programmed cell death protein 1,Inverse variance weighted,16,0.9 [0.75-1.08],0.2448073897021,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,XCL1,Lymphotactin,Inverse variance weighted,15,1.11 [0.93-1.33],0.246491366614711,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,15,0.91 [0.77-1.07],0.247072841763627,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,9,1.12 [0.92-1.36],0.250735309499227,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CCL20,C-C motif chemokine 20,Inverse variance weighted,6,0.91 [0.77-1.07],0.255579356171459,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,30,1.02 [0.98-1.06],0.259386673888781,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,C7,Complement component C7,Inverse variance weighted,26,0.97 [0.93-1.02],0.266913281726699,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,20,1.06 [0.96-1.16],0.275575364228857,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,2,0.62 [0.26-1.48],0.279334521071209,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,1.06 [0.95-1.19],0.280070057161072,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,6,1.26 [0.83-1.93],0.280147809672605,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,RNASET2,Ribonuclease T2,Inverse variance weighted,10,0.94 [0.83-1.06],0.281286858938742,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,15,0.92 [0.79-1.07],0.283649466465187,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,14,1.09 [0.93-1.27],0.293961276783209,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,6,0.85 [0.63-1.15],0.294307083249163,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,WNT9A,Protein Wnt-9a,Wald ratio,1,1.44 [0.72-2.85],0.299199922157984,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,27,1.06 [0.95-1.17],0.302330470479728,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,RNASE4,Ribonuclease 4,Inverse variance weighted,2,0.76 [0.45-1.28],0.303671114256225,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,9,1.21 [0.84-1.74],0.303675550525109,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,15,0.93 [0.81-1.07],0.311536698663199,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,4,1.12 [0.9-1.38],0.311614696407416,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD7,T-cell antigen CD7,Inverse variance weighted,12,0.97 [0.93-1.02],0.312801271611401,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CDH2,Cadherin-2,Inverse variance weighted,21,0.94 [0.83-1.06],0.314695971411099,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,0.88 [0.69-1.13],0.314996735509764,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,MMP12,Macrophage metalloelastase,Inverse variance weighted,2,1.24 [0.82-1.88],0.315579350645281,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,KLK11,Kallikrein-11,Inverse variance weighted,13,0.92 [0.79-1.08],0.316117286660639,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LMNB2,Lamin-B2,Inverse variance weighted,8,0.91 [0.75-1.1],0.322265262048626,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,EGFR,Epidermal growth factor receptor,Inverse variance weighted,8,1.15 [0.87-1.51],0.323015523263798,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PGF,Placenta growth factor,Inverse variance weighted,5,0.91 [0.75-1.1],0.32441141281368,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,20,1.09 [0.92-1.29],0.325625970442293,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,17,0.93 [0.79-1.08],0.32634727514021,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,15,1.06 [0.94-1.2],0.328572024739743,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FURIN,Furin,Inverse variance weighted,3,0.87 [0.65-1.16],0.329193915258305,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,18,0.94 [0.82-1.07],0.331156156184477,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CHGB,Secretogranin-1,Inverse variance weighted,7,1.07 [0.93-1.24],0.335421843800197,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NUCB2,Nucleobindin-2,Inverse variance weighted,2,1.21 [0.82-1.78],0.337247597916641,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,18,0.96 [0.88-1.05],0.340112169054097,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,1.12 [0.88-1.43],0.342407058438647,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PLXNB2,Plexin-B2,Inverse variance weighted,12,0.91 [0.75-1.11],0.343358639736142,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TFF2,Trefoil factor 2,Inverse variance weighted,16,0.95 [0.86-1.05],0.346898832573022,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,13,1.11 [0.89-1.39],0.350239871086109,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,0.91 [0.75-1.11],0.351107714656895,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,EFNA4,Ephrin-A4,Inverse variance weighted,2,1.14 [0.86-1.52],0.356250245085244,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NECTIN2,Nectin-2,Inverse variance weighted,3,1.2 [0.81-1.78],0.360516295861002,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,1.15 [0.85-1.55],0.360548359650352,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,9,1.09 [0.9-1.32],0.361000253435046,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,RSPO1,R-spondin-1,Inverse variance weighted,8,0.92 [0.77-1.1],0.36172537074837,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,BCAN,Brevican core protein,Inverse variance weighted,12,1.07 [0.93-1.23],0.362541461512784,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,0.96 [0.87-1.05],0.367548094807303,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CST3,Cystatin-C,Inverse variance weighted,3,0.82 [0.52-1.27],0.370014321940359,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,8,1.16 [0.84-1.61],0.372383189592233,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,22,0.96 [0.88-1.05],0.377702517107187,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,17,0.95 [0.84-1.07],0.378664137593356,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,0.95 [0.83-1.07],0.380938675305996,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SERPINF1,Pigment epithelium-derived factor,Wald ratio,1,1.31 [0.71-2.41],0.38515649341434,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,1.3 [0.72-2.35],0.38809624397332,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,25,0.95 [0.85-1.06],0.388387046990699,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,4,1.18 [0.81-1.72],0.390247870252495,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,1.14 [0.84-1.54],0.394717234905502,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CXCL11,C-X-C motif chemokine 11,Inverse variance weighted,11,1.07 [0.91-1.27],0.397478848467617,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,0.98 [0.95-1.02],0.397495775785037,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,5,0.84 [0.56-1.26],0.400974702255468,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FGF5,Fibroblast growth factor 5,Inverse variance weighted,18,1.04 [0.94-1.15],0.40398697211119,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TFF3,Trefoil factor 3,Inverse variance weighted,10,0.92 [0.75-1.12],0.404571036564475,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,11,1.12 [0.86-1.45],0.405822119729477,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CCL21,C-C motif chemokine 21,Inverse variance weighted,15,0.95 [0.83-1.08],0.406591684088086,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CCL16,C-C motif chemokine 16,Inverse variance weighted,26,0.98 [0.95-1.02],0.408019884140712,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL22,Interleukin-22,Inverse variance weighted,4,0.88 [0.66-1.19],0.412323252696947,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL15,Interleukin-15,Inverse variance weighted,35,1.03 [0.95-1.12],0.412844749662693,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ANGPT2,Angiopoietin-2,Inverse variance weighted,7,0.88 [0.65-1.19],0.414069938058897,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,VEGFD,Vascular endothelial growth factor D,Inverse variance weighted,7,1.08 [0.89-1.31],0.414340154957107,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,1.09 [0.89-1.32],0.41611177938002,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,24,0.94 [0.82-1.09],0.421170195476343,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CCN4,CCN family member 4,Inverse variance weighted,29,1.02 [0.97-1.08],0.422762255170775,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,EFNA1,Ephrin-A1,Inverse variance weighted,3,0.78 [0.42-1.44],0.423806857193193,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SPP1,Osteopontin,Inverse variance weighted,13,0.93 [0.78-1.11],0.424191238734539,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,0.94 [0.8-1.1],0.425240195639768,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GOLM2,Protein GOLM2,Inverse variance weighted,14,1.04 [0.94-1.14],0.427758433141101,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD163,Scavenger receptor cysteine-rich type 1 protein M130,Inverse variance weighted,38,1.04 [0.95-1.14],0.428739326927536,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CDH1,Cadherin-1,Inverse variance weighted,16,1.04 [0.94-1.16],0.43081227010041,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,1.07 [0.9-1.27],0.431885820092798,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,Inverse variance weighted,48,0.97 [0.91-1.04],0.432541944633679,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,0.86 [0.6-1.25],0.435146180519292,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,0.77 [0.41-1.47],0.436359356346312,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,3,0.88 [0.64-1.21],0.4378983143315,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,9,0.93 [0.78-1.11],0.449465105193058,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,RSPO3,R-spondin-3,Inverse variance weighted,5,0.84 [0.53-1.33],0.453242569547507,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,0.97 [0.88-1.06],0.45684377791671,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,0.88 [0.62-1.24],0.457205346848441,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD99,CD99 antigen,Inverse variance weighted,4,1.18 [0.76-1.83],0.459111447858259,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD55,Complement decay-accelerating factor,Inverse variance weighted,8,1.07 [0.89-1.28],0.46128151023144,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PSAP,Prosaposin,Inverse variance weighted,13,0.96 [0.87-1.06],0.465585562973186,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CTSD,Cathepsin D,Inverse variance weighted,7,1.15 [0.79-1.68],0.468579139692952,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL12A_IL12B,Interleukin-12,Inverse variance weighted,56,0.98 [0.94-1.03],0.46976208944943,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TFF1,Trefoil factor 1,Inverse variance weighted,14,1.03 [0.96-1.1],0.469765397676506,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,0.96 [0.85-1.08],0.471784774820075,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,11,0.93 [0.76-1.14],0.472629820694107,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,EBI3_IL27,Interleukin-27,Inverse variance weighted,26,0.97 [0.91-1.05],0.474594129466251,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,1.1 [0.85-1.41],0.47613305999803,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,4,0.92 [0.72-1.17],0.486275955549493,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,MDK,Midkine,Inverse variance weighted,14,1.05 [0.92-1.19],0.488328404688311,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,0.94 [0.78-1.12],0.491284438094717,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PRSS2,Trypsin-2,Inverse variance weighted,17,0.95 [0.82-1.1],0.499113497284134,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,6,0.92 [0.74-1.16],0.500541795890186,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GAST,Gastrin,Inverse variance weighted,9,0.95 [0.8-1.11],0.50343838764869,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,9,1.06 [0.89-1.27],0.506511031650504,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,1.09 [0.85-1.39],0.509236468564103,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Wald ratio,1,1.2 [0.7-2.07],0.51011032215606,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SCARA5,Scavenger receptor class A member 5,Wald ratio,1,0.85 [0.53-1.37],0.511539918834272,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,11,0.98 [0.91-1.05],0.511951023410725,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,1.05 [0.91-1.21],0.514322362437152,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,0.97 [0.87-1.07],0.51535337010992,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,0.97 [0.89-1.06],0.516025919917673,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CSTB,Cystatin-B,Inverse variance weighted,23,1.02 [0.97-1.07],0.517260047875902,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,INHBB,Inhibin beta B chain,Inverse variance weighted,11,1.07 [0.87-1.32],0.519857759512184,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,12,0.92 [0.72-1.18],0.527710297915626,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,0.94 [0.76-1.15],0.531368317142207,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,UMOD,Uromodulin,Inverse variance weighted,34,0.97 [0.9-1.06],0.53573895995197,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IMMT,MICOS complex subunit MIC60,Wald ratio,1,1.14 [0.75-1.73],0.536448568733968,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,0.98 [0.94-1.04],0.540827767286417,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PVR,Poliovirus receptor,Inverse variance weighted,3,1.11 [0.79-1.56],0.545030492506575,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,3,1.15 [0.73-1.81],0.548691423484712,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CTSZ,Cathepsin Z,Inverse variance weighted,16,1.02 [0.95-1.1],0.55173679196006,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,2,1.17 [0.69-1.97],0.554074271598305,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,0.98 [0.92-1.04],0.557702138456139,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,2,1.16 [0.7-1.94],0.562984395647295,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,35,1.02 [0.95-1.09],0.565651374387624,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1.11 [0.77-1.6],0.568019767709442,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SFTPA2,Pulmonary surfactant-associated protein A2,Inverse variance weighted,27,1.01 [0.97-1.05],0.573224104668562,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,7,1.08 [0.82-1.43],0.574176439953564,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,0.88 [0.56-1.38],0.57722848008349,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,5,1.07 [0.83-1.39],0.579013917365141,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,1.11 [0.76-1.64],0.581812784564122,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,OMG,Oligodendrocyte-myelin glycoprotein,Inverse variance weighted,15,1.03 [0.92-1.16],0.582735013473292,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,14,0.97 [0.86-1.09],0.587835457718784,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,0.92 [0.68-1.25],0.591497269486336,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,7,1.09 [0.79-1.5],0.593605479872193,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,1.03 [0.92-1.15],0.596576903435958,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CCN3,CCN family member 3,Inverse variance weighted,17,1.02 [0.95-1.1],0.596918017040825,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,0.96 [0.82-1.12],0.5979508167981,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,1.03 [0.92-1.16],0.598097003619338,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,2,1.13 [0.72-1.75],0.600369704433442,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NECTIN4,Nectin-4,Inverse variance weighted,4,0.91 [0.63-1.31],0.600972604037303,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,23,0.98 [0.89-1.07],0.601405451358729,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,OGN,Mimecan,Inverse variance weighted,37,0.99 [0.94-1.04],0.603008345184063,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,3,0.86 [0.47-1.54],0.604133176722963,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SEPTIN8,Septin-8,Inverse variance weighted,4,1.08 [0.81-1.42],0.607357373325668,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,AREG,Amphiregulin,Inverse variance weighted,5,1.06 [0.84-1.33],0.609974800362542,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,9,1.05 [0.87-1.27],0.611927348069636,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,5,0.94 [0.74-1.19],0.61412923565406,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,1.07 [0.82-1.39],0.614458248867965,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,11,0.94 [0.75-1.18],0.620547556789505,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,13,0.94 [0.73-1.2],0.620764185033507,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NPPC,C-type natriuretic peptide,Inverse variance weighted,3,0.86 [0.46-1.58],0.621019499373114,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CCL3,C-C motif chemokine 3,Inverse variance weighted,15,1.02 [0.93-1.13],0.621706024582516,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PCDH1,Protocadherin-1,Inverse variance weighted,4,1.04 [0.88-1.23],0.622476663283015,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,MSLN,Mesothelin,Inverse variance weighted,11,1.04 [0.88-1.24],0.624253058810714,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,DSC2,Desmocollin-2,Inverse variance weighted,16,1.02 [0.94-1.11],0.625927465904009,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.91 [0.61-1.35],0.626423240497315,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,2,1.08 [0.78-1.51],0.627083841434531,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,6,0.96 [0.81-1.13],0.628699900545577,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SLAMF8,SLAM family member 8,Inverse variance weighted,2,0.92 [0.65-1.3],0.636438860764326,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,0.98 [0.9-1.06],0.63669241563775,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,XG,Glycoprotein Xg,Inverse variance weighted,2,0.91 [0.6-1.36],0.637172886717663,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,0.87 [0.48-1.57],0.637524779729309,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SPON2,Spondin-2,Inverse variance weighted,3,1.08 [0.78-1.5],0.637574086605124,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FAM3B,Protein FAM3B,Inverse variance weighted,26,1.01 [0.97-1.06],0.638747448557788,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,THBS2,Thrombospondin-2,Inverse variance weighted,15,0.98 [0.89-1.07],0.640423695722314,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,DTNB,Dystrobrevin beta,Inverse variance weighted,2,1.09 [0.75-1.59],0.640486752408241,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,HYAL1,Hyaluronidase-1,Inverse variance weighted,19,0.98 [0.91-1.06],0.644129335757495,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,10,0.95 [0.76-1.19],0.657419069849639,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GUCA2A,Guanylin,Inverse variance weighted,7,0.93 [0.67-1.28],0.661572450937376,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,WFDC1,WAP four-disulfide core domain protein 1,Wald ratio,1,1.14 [0.63-2.08],0.666443621105163,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,13,0.96 [0.81-1.14],0.666929107141098,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,2,0.77 [0.23-2.58],0.66726084144817,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.96 [0.79-1.16],0.668423162818869,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SFTPA1,Pulmonary surfactant-associated protein A1,Inverse variance weighted,6,1.02 [0.94-1.1],0.668891446102951,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,8,1.09 [0.74-1.6],0.669127585858971,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD27,CD27 antigen,Inverse variance weighted,9,1.04 [0.87-1.25],0.669481763700693,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,8,0.96 [0.79-1.16],0.674222922538477,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.12 [0.67-1.86],0.676879524918039,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Inverse variance weighted,3,0.95 [0.75-1.21],0.677920569030433,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,27,1.01 [0.95-1.08],0.67834348056082,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,0.92 [0.61-1.38],0.681085728358908,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1.01 [0.97-1.05],0.681687479871594,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,3,0.93 [0.67-1.31],0.685196579378597,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CALCA,Calcitonin,Inverse variance weighted,13,1.06 [0.8-1.39],0.686620475233537,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ADA2,Adenosine deaminase 2,Inverse variance weighted,10,1.04 [0.87-1.23],0.687371545128653,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,0.97 [0.81-1.15],0.688457375677478,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,15,1.02 [0.93-1.12],0.694495264913452,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,0.83 [0.33-2.11],0.697561316409897,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,6,1.04 [0.85-1.28],0.697762264066523,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,28,1.02 [0.94-1.1],0.699500495976701,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CGA,Glycoprotein hormones alpha chain,Inverse variance weighted,2,0.92 [0.58-1.46],0.711016558360988,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,39,0.99 [0.92-1.06],0.712300722147991,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.02 [0.94-1.1],0.714722864625162,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SPON1,Spondin-1,Inverse variance weighted,4,0.96 [0.74-1.23],0.717837476833767,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SIGLEC1,Sialoadhesin,Inverse variance weighted,16,1.02 [0.92-1.13],0.718368491498318,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,7,1.01 [0.94-1.09],0.719100148534777,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,0.85 [0.35-2.05],0.720628379015826,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,REN,Renin,Inverse variance weighted,8,1.04 [0.85-1.27],0.722365861129559,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,19,0.99 [0.91-1.07],0.731316855229836,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,5,0.96 [0.77-1.2],0.732053117723145,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SEMA3F,Semaphorin-3F,Inverse variance weighted,32,0.99 [0.91-1.07],0.732692594105125,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,4,1.05 [0.79-1.4],0.733357030648878,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,16,0.98 [0.87-1.1],0.733961238381819,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,0.94 [0.67-1.33],0.737377421802259,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,1.05 [0.76-1.47],0.7497656305518,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CCL14,C-C motif chemokine 14,Inverse variance weighted,17,0.99 [0.95-1.04],0.754644974903468,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Inverse variance weighted,3,0.92 [0.56-1.53],0.756336746049258,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FAM3C,Protein FAM3C,Inverse variance weighted,3,0.96 [0.74-1.25],0.756432170740846,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,10,0.98 [0.88-1.1],0.761766150113789,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,1.09 [0.61-1.95],0.772524399003896,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LAMB1,Laminin subunit beta-1,Inverse variance weighted,21,1.01 [0.93-1.09],0.777699947726968,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CTSO,Cathepsin O,Inverse variance weighted,19,0.98 [0.88-1.1],0.780518606090611,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,MMP7,Matrilysin,Wald ratio,1,1.03 [0.82-1.29],0.789717920867183,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.96 [0.73-1.28],0.793503126747527,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,29,1.01 [0.92-1.12],0.795001400537656,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD160,CD160 antigen,Inverse variance weighted,24,1.02 [0.9-1.14],0.800004636043233,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CHGA,Chromogranin-A,Inverse variance weighted,5,0.97 [0.76-1.23],0.800797354761944,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,22,1.01 [0.96-1.06],0.801199609760198,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CNTN5,Contactin-5,Inverse variance weighted,22,0.99 [0.9-1.09],0.80250180863462,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,0.97 [0.75-1.25],0.803251473659914,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,MME,Neprilysin,Inverse variance weighted,46,0.99 [0.94-1.05],0.803609849800316,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,12,1.03 [0.79-1.34],0.806699598706402,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,21,0.99 [0.9-1.08],0.806793056592115,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SCG2,Secretogranin-2,Inverse variance weighted,2,0.96 [0.71-1.31],0.807594017192275,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CLMP,CXADR-like membrane protein,Inverse variance weighted,4,1.04 [0.75-1.44],0.812970725248337,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,1.02 [0.88-1.18],0.813177593348182,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GDF15,Growth/differentiation factor 15,Wald ratio,1,0.92 [0.45-1.88],0.814512015227142,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,F9,Coagulation factor IX,Inverse variance weighted,3,0.97 [0.71-1.3],0.816179239560745,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,11,1.03 [0.78-1.36],0.817176052091727,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CFC1,Cryptic protein,Inverse variance weighted,11,0.98 [0.81-1.19],0.818134611889692,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,9,1.02 [0.84-1.25],0.818228224381471,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,MMP3,Stromelysin-1,Inverse variance weighted,4,1.05 [0.66-1.68],0.82160015954535,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SNCG,Gamma-synuclein,Inverse variance weighted,47,1 [0.97-1.04],0.824925351933097,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,COLEC12,Collectin-12,Inverse variance weighted,3,1.04 [0.74-1.46],0.825893828187485,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,0.97 [0.77-1.23],0.833440174915869,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD300A,CMRF35-like molecule 8,Inverse variance weighted,35,1.01 [0.95-1.06],0.836234314827306,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,13,1.01 [0.88-1.16],0.837159969700931,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,STC1,Stanniocalcin-1,Inverse variance weighted,9,1.02 [0.83-1.26],0.837279194900563,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.93 [0.48-1.82],0.837533647843131,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,4,0.92 [0.4-2.12],0.841383595331069,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,1.04 [0.69-1.58],0.844609924162724,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TCN2,Transcobalamin-2,Inverse variance weighted,24,0.99 [0.94-1.05],0.845771169015754,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,4,0.96 [0.62-1.49],0.847273791469463,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL18,Interleukin-18,Inverse variance weighted,26,0.99 [0.91-1.08],0.848825859424341,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,RBP2,Retinol-binding protein 2,Inverse variance weighted,5,0.96 [0.63-1.48],0.864204461644086,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.96 [0.61-1.52],0.870432757061591,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CCL22,C-C motif chemokine 22,Inverse variance weighted,8,1.03 [0.71-1.5],0.874278273986343,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,20,0.99 [0.89-1.1],0.876771764263913,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,12,1.03 [0.69-1.54],0.877627027272733,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,KLK4,Kallikrein-4,Inverse variance weighted,5,1.03 [0.65-1.64],0.883804731633272,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,16,0.99 [0.85-1.15],0.885457955809388,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,7,0.97 [0.66-1.44],0.8887073185212,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,1.01 [0.82-1.25],0.891929516474949,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CCL23,C-C motif chemokine 23,Inverse variance weighted,23,1 [0.95-1.05],0.893232330877133,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,1.02 [0.78-1.32],0.893324483030263,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,0.99 [0.88-1.12],0.89432963135845,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CCL7,C-C motif chemokine 7,Inverse variance weighted,14,1.01 [0.91-1.12],0.894980418817891,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,10,1.02 [0.76-1.37],0.896931919223174,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,6,0.98 [0.73-1.31],0.899528201047357,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,1 [0.95-1.06],0.903126996318926,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,6,0.98 [0.73-1.31],0.905004501648205,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,7,1.02 [0.71-1.48],0.907065723688071,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,8,1.02 [0.78-1.31],0.909461008741824,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,OCLN,Occludin,Inverse variance weighted,2,1.05 [0.43-2.59],0.913732130023852,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD93,Complement component C1q receptor,Inverse variance weighted,2,0.98 [0.72-1.35],0.916941569602645,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,10,0.99 [0.77-1.26],0.917484427983597,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD46,Membrane cofactor protein,Inverse variance weighted,2,1.02 [0.75-1.37],0.920665576501303,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,HNMT,Histamine N-methyltransferase,Inverse variance weighted,10,1.01 [0.85-1.2],0.92140007039719,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,HGF,Hepatocyte growth factor,Inverse variance weighted,5,1.01 [0.8-1.27],0.925375918697762,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FOLR1,Folate receptor alpha,Inverse variance weighted,6,1.01 [0.83-1.22],0.939357614370938,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,12,1 [0.88-1.15],0.944967219692504,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,RTBDN,Retbindin,Inverse variance weighted,2,1.01 [0.68-1.51],0.946686761116096,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,1.01 [0.81-1.24],0.947540129707057,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,AMBP,Protein AMBP,Inverse variance weighted,5,0.99 [0.73-1.35],0.951696508689588,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,2,1.01 [0.75-1.36],0.95934257738685,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CLEC3B,Tetranectin,Inverse variance weighted,2,1.01 [0.65-1.57],0.972493350198112,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,DPY30,Protein dpy-30 homolog,Wald ratio,1,0.99 [0.6-1.64],0.98179364207905,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,7,1 [0.78-1.27],0.991416048718778,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LAYN,Layilin,Inverse variance weighted,3,1 [0.57-1.78],0.994397484598474,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,1 [0.41-2.41],0.994916412081076,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,11,1 [0.79-1.26],0.995604308377705,trans
